购物车
- 全部删除
- 您的购物车当前为空
HS38 是一种特异性的 ATP 竞争性 DAPK 抑制剂,对 DAPK1、PIM3 和 ZIPK 的 Kds 分别为 300 nM、200 nM 和 280 nM。 HS38 可用于平滑肌相关疾病的研究。
为众多的药物研发团队赋能,
让新药发现更简单!
HS38 是一种特异性的 ATP 竞争性 DAPK 抑制剂,对 DAPK1、PIM3 和 ZIPK 的 Kds 分别为 300 nM、200 nM 和 280 nM。 HS38 可用于平滑肌相关疾病的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 196 | 现货 | |
5 mg | ¥ 455 | 现货 | |
10 mg | ¥ 672 | 现货 | |
25 mg | ¥ 1,330 | 现货 | |
50 mg | ¥ 2,160 | 现货 | |
100 mg | ¥ 3,460 | 现货 | |
200 mg | ¥ 4,930 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 490 | 现货 |
产品描述 | HS38 is a specific and ATP-competitive DAPK inhibitor with Kds of 300 nM, 200 nM, and 280 nM for DAPK1, PIM3, and ZIPK. HS38 can be used in studies about smooth muscle-related disorders. |
靶点活性 | DAPK2:79 nM (Kd), DAPK1:300 nM (Kd), DAPK1:IC50 : 200 nM, Pim3:200 nM (Kd), ZIPK:280 nM (Kd) |
体外活性 | HS38 shows a Kd of 79 nM for DAPK2. In human aortic SM cells, HS38 reduces relative RLC20 phosphorylation in both the basal and S1P-activated states. In Ca2+-sensitized rabbit ileum, HS38 reduces the contractile force, MYPT1 phosphorylation, and RLC20 phosphorylation[1]. |
别名 | HS 38, HS-38 |
分子量 | 349.8 |
分子式 | C14H12ClN5O2S |
CAS No. | 1030203-81-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 6.4 mg/mL (18.4 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.